Zheng H - Search Results

1

ALDH(+)/CD44(+) cells in breast cancer are associated with worse prognosis and poor clinical outcome.

Qiu Y, Pu T, Guo P, Wei B, Zhang Z, Zhang H, Zhong X, Zheng H, Chen L, Bu H, Ye F. Qiu Y, et al. Among authors: zheng h. Exp Mol Pathol. 2016 Feb;100(1):145-50. doi: 10.1016/j.yexmp.2015.11.032. Epub 2015 Dec 11. Exp Mol Pathol. 2016. PMID: 26687806

2

[Significance of HER2 testing in breast cancer].

Ni YB, Yang WJ, Bu H, Zheng H. Ni YB, et al. Among authors: zheng h. Zhonghua Bing Li Xue Za Zhi. 2011 Feb;40(2):76-8. Zhonghua Bing Li Xue Za Zhi. 2011. PMID: 21426800 Chinese. No abstract available.

3

Membrane-bound complement regulatory proteins are prognostic factors of operable breast cancer treated with adjuvant trastuzumab: a retrospective study.

Liu M, Yang YJ, Zheng H, Zhong XR, Wang Y, Wang Z, Wang YG, Wang YP. Liu M, et al. Among authors: zheng h. Oncol Rep. 2014 Dec;32(6):2619-27. doi: 10.3892/or.2014.3496. Epub 2014 Sep 18. Oncol Rep. 2014. PMID: 25241923

4

Application status of tamoxifen in endocrine therapy for early breast cancer.

Hu Q, Luo T, Zhong X, He P, Tian T, Zheng H. Hu Q, et al. Among authors: zheng h. Exp Ther Med. 2015 Jun;9(6):2207-2212. doi: 10.3892/etm.2015.2437. Epub 2015 Apr 20. Exp Ther Med. 2015. PMID: 26136961 Free PMC article.

5

The Impact of Different Preservation Conditions and Freezing-Thawing Cycles on Quality of RNA, DNA, and Proteins in Cancer Tissue.

Wang Y, Zheng H, Chen J, Zhong X, Wang Y, Wang Z, Wang Y. Wang Y, et al. Among authors: zheng h. Biopreserv Biobank. 2015 Oct;13(5):335-47. doi: 10.1089/bio.2015.0029. Biopreserv Biobank. 2015. PMID: 26484573

6

Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.

Zhong X, Dong Z, Dong H, Li J, Peng Z, Deng L, Zhu X, Sun Y, Lu X, Shen F, Su X, Zhang L, Gu Y, Zheng H. Zhong X, et al. Among authors: zheng h. PLoS One. 2016 Jun 3;11(6):e0156789. doi: 10.1371/journal.pone.0156789. eCollection 2016. PLoS One. 2016. PMID: 27257965 Free PMC article.

7

Treatment and survival patterns of Chinese patients diagnosed with breast cancer between 2005 and 2009 in Southwest China: An observational, population-based cohort study.

Peng Z, Wei J, Lu X, Zheng H, Zhong X, Gao W, Chen Y, Jing J. Peng Z, et al. Among authors: zheng h. Medicine (Baltimore). 2016 Jun;95(25):e3865. doi: 10.1097/MD.0000000000003865. Medicine (Baltimore). 2016. PMID: 27336872 Free PMC article.

8

MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapy.

Zhong X, Xie G, Zhang Z, Wang Z, Wang Y, Wang Y, Qiu Y, Li L, Bu H, Li J, Zheng H. Zhong X, et al. Among authors: zheng h. Oncotarget. 2016 Sep 20;7(38):61166-61182. doi: 10.18632/oncotarget.11278. Oncotarget. 2016. PMID: 27533459 Free PMC article.

9

ADAMTS6 suppresses tumor progression via the ERK signaling pathway and serves as a prognostic marker in human breast cancer.

Xie Y, Gou Q, Xie K, Wang Z, Wang Y, Zheng H. Xie Y, et al. Among authors: zheng h. Oncotarget. 2016 Sep 20;7(38):61273-61283. doi: 10.18632/oncotarget.11341. Oncotarget. 2016. PMID: 27542224 Free PMC article.

10

Diagnosis and treatment pattern among rural and urban breast cancer patients in Southwest China from 2005 to 2009.

Peng Z, Wei J, Lu X, Zheng H, Zhong X, Gao W, Chen Y, Jing J. Peng Z, et al. Among authors: zheng h. Oncotarget. 2016 Nov 22;7(47):78168-78179. doi: 10.18632/oncotarget.11375. Oncotarget. 2016. PMID: 27556301 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,107 results

Search Page

Filters